SDIC
SRPT icon

South Dakota Investment Council’s Sarepta Therapeutics SRPT Stock Holding History

South Dakota Investment Council’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-653
Closed -$11K – 635
2025
Q2 		$11K Sell
653
-9,500
-94% -$405K ﹤0.01% 610
2025
Q1 		$648K Hold
10,153
– – 0.01% 470
2024
Q4 		$1.24M Sell
10,153
-14,956
-60% -$1.83M 0.02% 385
2024
Q3 		$3.14M Hold
25,109
– – 0.06% 255
2024
Q2 		$3.97M Buy
+25,109
New +$3.23M 0.08% 208

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

South Dakota Investment Council's SRPT Position: Q3 2025 in Review

South Dakota Investment Council sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 653 shares — an estimated $11K sold.

South Dakota Investment Council first reported a position in SRPT in Q2 2024 and held it in 5 quarters. The position peaked at $3.97M in Q2 2024. 320 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • South Dakota Investment Council reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • South Dakota Investment Council sold 653 Sarepta Therapeutics shares in Q3 2025, an estimated $11K.
  • South Dakota Investment Council first reported a position in Sarepta Therapeutics in Q2 2024 and held it in 5 quarters.
  • South Dakota Investment Council's Sarepta Therapeutics position peaked at $3.97M in Q2 2024.
  • 320 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on South Dakota Investment Council's 13F filing for Q3 2025, filed 12 Nov 2025.